Further studies including the effect of MSH3-silencing on other repeats as well as a possible enhancer-effect under MLH1- or MSH2-deficient conditions are needed for a better understanding of the consequences of MSH3-deficiency in certain types of CRC. Here, MSH3 is linked to colorectal carcinoma.